Blue Owl Capital Holdings LP
Filing Date
Global Rank
#3,300
/ 7,976
▲ 65
Top Industry
Biotechnology
52.6%
3Y Alpha vs SPY
-10.9%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
16 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+32.5%
SPY
+76.5%
Annualised alpha
-11.0%
Max drawdown
−46.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
43 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
13.5%
−9.7 pts
Top 5
40.7%
−10.4 pts
Top 10
63.0%
−6.9 pts
HHI
537
Diversified−331
Portfolio Trend
16 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 56.0% | $176,812,952 |
| Financial Services | 23.9% | $75,465,356 |
| Technology | 12.6% | $39,698,525 |
| Consumer Cyclical | 7.2% | $22,568,266 |
| Energy | 0.3% | $978,438 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | +925,000 | 5,853,040 | $18,905,319 | |
| HLLY | Holley Inc. | +750,000 | 4,862,361 | $15,267,813 | |
| CMPS | COMPASS Pathways plc | +375,000 | 604,914 | $3,466,157 | |
| AQST | Aquestive Therapeutics, Inc. | +330,000 | 1,250,000 | $6,987,500 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +167,200 | 422,438 | $12,706,935 | |
| CGEM | Cullinan Therapeutics, Inc. | +125,000 | 2,510,972 | $14,890,063 | |
| DELL | Dell Technologies Inc. | +31,486 | 52,334 | $7,419,391 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NCDL | Nuveen Churchill Direct Lending Corp. | −948,000 | 3,091,553 | $42,663,431 | |
| TNGX | Tango Therapeutics, Inc. | −695,000 | 119,416 | $1,003,094 | |
| ENGN | enGene Therapeutics Inc. | −450,000 | 3,278,106 | $22,389,463 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −350,000 | 979,912 | $2,537,972 | |
| MLYS | Mineralys Therapeutics, Inc. | −235,000 | 100,944 | $3,827,796 | |
| EYPT | EyePoint, Inc. | −195,000 | 367,594 | $5,234,538 | |
| CNTA | Centessa Pharmaceuticals plc | −161,150 | 169,450 | $4,109,162 | |
| PVLA | Palvella Therapeutics, Inc. | −30,000 | 95,259 | $5,971,786 | |
| KRRO | Korro Bio, Inc. | −20,000 | 105,000 | $5,028,450 | |
| IRON | Disc Medicine, Inc. | −20,000 | 102,260 | $6,757,340 | |
| TTAN | ServiceTitan, Inc. | −6,396 | 4,954 | $499,511 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 988,249 | $14,952,207 | |
| IMA | ImageneBio, Inc. | 540,924 | $4,408,530 | |
| IMRX | Immuneering Corp | 550,000 | $3,850,000 | |
| NU | Nu Holdings Ltd. | 173,873 | $2,783,706 | |
| MREO | Mereo BioPharma Group plc | 1,250,000 | $2,575,000 | |
| ACLX | Arcellx, Inc. | 26,823 | $2,202,168 | |
| KALV | KalVista Pharmaceuticals, Inc. | 125,000 | $1,522,500 | |
| GTLB | Gitlab Inc. | 12,352 | $556,828 | |
| PIPR | Piper Sandler Companies | 607 | $52,655 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. | 80,167 | $5,093,811 | |
| STWD | Starwood Property Trust, Inc. | 131,461 | $2,638,422 | |
| BMEA | Biomea Fusion, Inc. | 1,300,000 | $2,340,000 | |
| CABA | Cabaletta Bio, Inc. | 1,125,000 | $1,710,000 | |
| APGE | Apogee Therapeutics, Inc. | 35,000 | $1,520,050 | |
| RZLV | Rezolve Ai PLC | 181,667 | $558,626 | |
| KPLT | Katapult Holdings, Inc. | 5,421 | $43,422 | |
| No positions match the current search. | ||||
43 positions ·
$315,523,537 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NCDL |
Nuveen Churchill Direct Lending Corp.
Financial Services
|
Reduced | 3,091,553 | $42,663,431 | 13.52% | |
| OBDC |
Blue Owl Capital Corp
Financial Services
|
Held | 2,045,070 | $26,115,543 | 8.28% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 3,278,106 | $22,389,463 | 7.10% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Added | 5,853,040 | $18,905,319 | 5.99% | |
| EVCM |
EverCommerce Inc.
Technology
|
Held | 1,641,929 | $18,274,669 | 5.79% | |
| HLLY |
Holley Inc.
Consumer Cyclical
|
Added | 4,862,361 | $15,267,813 | 4.84% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
NEW | 988,249 | $14,952,207 | 4.74% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Added | 2,510,972 | $14,890,063 | 4.72% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 422,438 | $12,706,935 | 4.03% | |
| CNDT |
CONDUENT Inc
Technology
|
Held | 4,456,848 | $12,479,174 | 3.96% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
Held | 1,328,351 | $9,112,487 | 2.89% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 2,591,525 | $9,070,337 | 2.87% | |
| DELL |
Dell Technologies Inc.
Technology
|
Added | 52,334 | $7,419,391 | 2.35% | |
| CVEO |
Civeo Corp
Consumer Cyclical
|
Held | 317,411 | $7,300,453 | 2.31% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 7,407,906 | $7,178,260 | 2.28% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Added | 1,250,000 | $6,987,500 | 2.21% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 102,260 | $6,757,340 | 2.14% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Reduced | 95,259 | $5,971,786 | 1.89% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Reduced | 367,594 | $5,234,538 | 1.66% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Reduced | 105,000 | $5,028,450 | 1.59% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
NEW | 540,924 | $4,408,530 | 1.40% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 2,969,199 | $4,394,414 | 1.39% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 169,450 | $4,109,162 | 1.30% | |
| IMRX |
Immuneering Corp
Healthcare
|
NEW | 550,000 | $3,850,000 | 1.22% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 100,944 | $3,827,796 | 1.21% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 604,914 | $3,466,157 | 1.10% | |
| FLD |
Fold Holdings, Inc.
Financial Services
|
Held | 856,632 | $3,306,599 | 1.05% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Held | 733,568 | $2,934,272 | 0.93% | |
| NU |
Nu Holdings Ltd.
Financial Services
|
NEW | 173,873 | $2,783,706 | 0.88% | |
| MREO |
Mereo BioPharma Group plc
Healthcare
|
NEW | 1,250,000 | $2,575,000 | 0.82% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Reduced | 979,912 | $2,537,972 | 0.80% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
NEW | 26,823 | $2,202,168 | 0.70% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
NEW | 125,000 | $1,522,500 | 0.48% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 119,416 | $1,003,094 | 0.32% | |
| EPD |
Enterprise Products Partners L.P.
Energy
|
Held | 31,290 | $978,438 | 0.31% | |
| GTLB |
Gitlab Inc.
Technology
|
NEW | 12,352 | $556,828 | 0.18% | |
| SHFS |
SHF Holdings, Inc.
Financial Services
|
Held | 75,897 | $543,422 | 0.17% | |
| TTAN |
ServiceTitan, Inc.
Technology
|
Reduced | 4,954 | $499,511 | 0.16% | |
| MRKR |
Marker Therapeutics, Inc.
Healthcare
|
Held | 554,250 | $493,282 | 0.16% | |
| AMOD |
Alpha Modus Holdings, Inc.
Technology
|
Held | 394,078 | $468,952 | 0.15% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Held | 1,718 | $269,657 | 0.09% | |
| PIPR |
Piper Sandler Companies
Financial Services
|
NEW | 607 | $52,655 | 0.02% | |
| AEON |
AEON Biopharma, Inc.
Healthcare
|
Held | 42,353 | $34,263 | 0.01% |